Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Wetzels

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Nephrology (Carlton, Vic.)|August 18, 2015
Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B-cellsIlse M Rood, Job Huussen, Jack F Wetzels, et al.
Expert Review of Clinical Pharmacology|August 19, 2016
Pharmacological treatment of primary membranous nephropathy in 2016Anne-Els van de Logt, Julia M Hofstra, Jack F Wetzels
Kidney International|October 16, 2019
The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discoveryAnne-Els van de Logt, Maryline Fresquet, Jack F Wetzels, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2007
Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamideAmanda J Branten, Peggy W du Buf-Vereijken, Marc Vervloet, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2016
Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test StudyAnneke P Bech, Jack F Wetzels, Ernie M H F Bongers, et al.
Nature Reviews. Nephrology|November 8, 2016
Minimal change disease and idiopathic FSGS: manifestations of the same diseaseRutger J Maas, Jeroen K Deegens, Bart Smeets, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patientsGerald Vervoort, Jack F Wetzels, Jos A Lutterman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 9, 2011
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathyJulia M Hofstra, Laurence H Beck, David M Beck, et al.
Nature Reviews. Nephrology|May 21, 2021
Therapeutic trials in adult FSGS: lessons learned and the road forwardAn S De Vriese, Jack F Wetzels, Richard J Glassock, et al.
Clinical Kidney Journal|December 7, 2019
Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literaturePaul de Laat, Nienke van Engelen, Jack F Wetzels, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Nephrology (Carlton, Vic.)|August 18, 2015
Rituximab can induce remission of nephrotic syndrome in the absence of peripheral B-cellsIlse M Rood, Job Huussen, Jack F Wetzels, et al.
Expert Review of Clinical Pharmacology|August 19, 2016
Pharmacological treatment of primary membranous nephropathy in 2016Anne-Els van de Logt, Julia M Hofstra, Jack F Wetzels
Kidney International|October 16, 2019
The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discoveryAnne-Els van de Logt, Maryline Fresquet, Jack F Wetzels, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2007
Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamideAmanda J Branten, Peggy W du Buf-Vereijken, Marc Vervloet, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2016
Thiazide Responsiveness Testing in Patients With Renal Magnesium Wasting and Correlation With Genetic Analysis: A Diagnostic Test StudyAnneke P Bech, Jack F Wetzels, Ernie M H F Bongers, et al.
Nature Reviews. Nephrology|November 8, 2016
Minimal change disease and idiopathic FSGS: manifestations of the same diseaseRutger J Maas, Jeroen K Deegens, Bart Smeets, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patientsGerald Vervoort, Jack F Wetzels, Jos A Lutterman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 9, 2011
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathyJulia M Hofstra, Laurence H Beck, David M Beck, et al.
Nature Reviews. Nephrology|May 21, 2021
Therapeutic trials in adult FSGS: lessons learned and the road forwardAn S De Vriese, Jack F Wetzels, Richard J Glassock, et al.
Clinical Kidney Journal|December 7, 2019
Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literaturePaul de Laat, Nienke van Engelen, Jack F Wetzels, et al.
Pageof 6